Immunoassay Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Immunoassay Market Over The Forecast Period?

The immunoassay market has demonstrated substantial expansion in recent years, and this positive trend is set to continue. It is forecast to increase from $37.32 billion in 2025 to $40.07 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The market’s past growth has been driven by several key factors, including the increasing prevalence of infectious and chronic diseases, higher volumes in clinical laboratory testing, the broad acceptance of elisa-based diagnostics, the expansion of pharmaceutical research activities, and a greater demand for early disease detection.

The immunoassay market is projected to experience robust expansion over the coming years, reaching a valuation of $52.83 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from several factors, including the escalating need for rapid diagnostic solutions, increased capital allocation towards personalized medicine, the proliferation of decentralized testing approaches, the expanding integration of digital processes in laboratories, and a heightened emphasis on companion diagnostics. Key developments expected within this period involve the greater uptake of high-sensitivity immunoassay kits, the increasing deployment of automated immunoassay analyzers, a rising call for point-of-care immunoassay examinations, the broadening scope of multiplex immunoassay technologies, and improved incorporation of data management software.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Growth Factors Are Strengthening The Immunoassay Market Landscape?

The anticipated expansion of the immunoassay market is linked to the growing incidence of infectious and chronic diseases. These illnesses encompass diseases stemming from pathogens or persistent medical conditions necessitating continuous oversight, diagnosis, and treatment. An uptick in environmental pollutant exposure, which compromises immunity and heightens disease vulnerability, is contributing to their rise. The fast spread of infectious and chronic conditions is boosting demand in the immunoassay market, prompting companies to implement sophisticated diagnostic instruments for prompt detection, disease monitoring, and precise clinical judgments. As an illustration, the UK Health Security Agency (UKHSA), a government public health agency in the United Kingdom, reported in June 2025 that Campylobacter cases in England rose from 60,055 in 2023 to 70,352 in 2024, marking an increase of 10,297 cases (17.1%) and a jump in the reporting rate from 104.1 to 121.9 per 100,000 population. Consequently, the expanding prevalence of infectious and chronic illnesses is fueling the need for the immunoassay market.

What Are The Major Segment Categories Within The Immunoassay Market?

The immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies And CROs, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

What Trends Are Influencing The Immunoassay Market Outlook?

Prominent companies within the immunoassay market are launching cutting-edge immunoassay analyzers to gain a competitive advantage. These laboratory instruments are specifically designed to automate and simplify the detection and measurement of biological molecules, such as proteins or hormones, by employing immunological reactions. For example, in May 2023, Beckman Coulter Diagnostics, a US-based company focused on creating products that simplify, automate, and innovate complex biomedical testing, introduced the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Access Immunoassay Analyzer is engineered to satisfy the needs of clinical laboratories regarding speed, dependability, consistency, quality, and the expansion of available tests. It has shown the ability to develop increasingly sensitive and clinically relevant assays, which in turn amplifies the effectiveness of new pharmaceutical therapies and ultimately enhances patient outcomes. This system incorporates innovations like advanced analyte processing and detection technology, precise sensors, intelligent algorithms, and remote real-time system monitoring, distinguishing itself as the only immunoassay analyzer system that requires no daily maintenance.

Who Are The Businesses Driving Activity In The Immunoassay Market?

Major companies operating in the immunoassay market are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Access The Complete Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Which Area Represents The Largest Portion Of The Immunoassay Market?

North America was the largest region in the immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Immunoassay Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Browse Through More Reports Similar to the Global Immunoassay Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunomodulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Immune Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/immune-health-supplements-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795